AMSBIO: Consistent High Quality Cell Line Controls

Hits:1100   Date: 11/3/2018

AMSBIO has expanded its range of high quality FFPE cancer cell line controls for immunohistochemistry (IHC), in situ hybridization (ISH) and Next Generation Sequencing (NGS) applications.

Variations in FFPE tissue sample quality and experimental setup can lead to misleading results without reliable controls. Traditional cell or tissue-based control specimens often present intra specimen variation, lot-to-lot variations and inconsistent biomolecule quality, driving a need for higher quality controls. 
 

CellMax™ FFPE cell line products are highly affordable and consistent controls manufactured using a patent-pending process that maintains both cell morphology and preserves nucleic acids and proteins. Cells are harvested by a proprietary trypsin-free method, preserving cell surface antigens and inflicting minimal physical damage that could lead to a loss of biomarkers. With over 100 tumor cell lines from major cancer types, controls are available in an unmatched variety of formats, including whole blocks, arrays and scrolls that can be tailor made to suit any your workflow. These cell line controls exhibit highly consistent density and homogeneity across the entire cell pellet slide and throughout a whole block ensuring accurate results time after time. 

The CellMax™ FFPE range of cancer cell line standards present a renewable source of positive and negative controls for assay development and routine analysis. For further information please visithttp://www.amsbio.com/cell_line_control_slides.aspx or contact AMSBIO on +44-1235-828200/ +1-617-945-5033 / info@amsbio.com.
 

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO can draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective.

Worldwide HQ 

AMS Biotechnology (AMSBIO)

184 Milton Park
Abingdon Oxon OX14 4SE UK
Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com 
Web www.amsbio.com

North American HQ

AMSBIO LLC
1035 Cambridge Street
Cambridge MA 02141 USA
Tel: +1.617.945.5033 
Tel: +1.800.987.0985 (toll free)
Email: info@amsbio.com 
Web www.amsbio.com